# Jimini Health

> Jimini Health is a New York-based behavioral health technology company building clinician-supervised AI for mental health care. Its platform, Sage, is an AI behavioral health assistant that supports patients before, during, and between therapy sessions while keeping licensed clinicians in oversight of every interaction. Founded in 2023 by AI and biotech veterans Luis Voloch, Mark Jacobstein, and Sahil Sud, the company pairs evidence-based practices like CBT with measurement-based care to improve both the effectiveness of and access to therapy. Jimini has raised more than $25M, including a $17M seed round in 2026.

- **Founded:** 2023
- **Headquarters:** New York, New York, United States
- **Founders:** Luis Voloch (Co-founder & CEO), Mark Jacobstein (Co-founder & President), Sahil Sud (Co-founder)
- **Team size:** ~23 employees
- **Products:** Sage, Clinical platform for provider organizations
- **Notable:** Raised more than $25M total, including a $17M seed round in March 2026, Early clinical data showing ~36% reduction in depression symptoms with roughly half the in-person sessions of standard outpatient care, Founding team includes Luis Voloch, co-founder of Immunai, an AI cancer-immunotherapy company valued at over $1B

## Products & services

- **Sage** — An AI behavioral health assistant that supports patients before, during, and between therapy sessions - offering reminders, practice exercises, and emotional support while following clinical guidance. Every interaction is visible to the patient's clinical team, and Sage escalates critical situations to clinicians who retain all care decisions.
- **Clinical platform for provider organizations** — AI-augmented care delivery infrastructure for behavioral health provider organizations, built around measurement-based care, evidence-based practices, and privacy-protected clinician oversight.

## Achievements

- Raised more than $25M total, including a $17M seed round in March 2026
- Early clinical data showing ~36% reduction in depression symptoms with roughly half the in-person sessions of standard outpatient care
- Founding team includes Luis Voloch, co-founder of Immunai, an AI cancer-immunotherapy company valued at over $1B
- Endorsements from clinical and academic leaders including Stanford's Dr. Johannes Eichstaedt

## Latest updates

- **2026-03** — Raised $17M seed round led by M13 and Town Hall Ventures, bringing total funding above $25M; plans to expand provider partnerships and clinical capabilities.
- **2024-11** — Launched publicly with $8M pre-seed funding and introduced Sage, its clinician-supervised AI therapist assistant.

## Links

- Website: https://jiminihealth.com
- LinkedIn: https://www.linkedin.com/company/jiminihealth

---

Profile page: https://yespress.io/jimini-health
Published by YesPress — https://yespress.io
Last updated: 2026-08-04